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Variation in Rheumatoid Hand and Wrist Surgery
among Medicare Beneficiaries: A Population-based
Cohort Study

Lin Zhong, Kevin C. Chung, Onur Baser, David A. Fox, Huseyin Yuce, and Jennifer F. Waljee
ABSTRACT. Objective. To examine the rate and variation in rheumatoid arthritis (RA)-related hand and wrist
surgery among Medicare (elderly) beneficiaries in the United States, and to identify the patient and
provider factors that influence surgical rates.
Methods. Using the 2006–2010 100% Medicare claims data of beneficiaries with RA diagnosis, we
examined rates of rheumatoid hand and wrist arthroplasty, arthrodesis, and hand tendon reconstruction in the United States. We used multivariate logistic regression models to examine variation
in receipt of surgery by patient and regional characteristics (density of providers, intensity of use of
biologic disease-modifying antirheumatic drugs).
Results. Between 2006 and 2010, the annual rate of RA-related hand and wrist arthroplasty or
arthrodesis was 23.1 per 10,000 patients, and the annual rate of hand tendon reconstruction was 4.2
per 10,000 patients. The rates of surgery varied 9-fold across hospital referral regions in the United
States. Younger patient age, female sex, white race, higher socioeconomic status (SES), and rural
residence were associated with a higher likelihood of undergoing arthroplasty and arthrodesis. We
observed a significant decline in rate of arthroplasty and arthrodesis with increasing density of
rheumatologists. Tendon reconstruction was not influenced by provider factors, but was correlated
with age, race, SES, and rural status of the patients.
Conclusion. Surgical reconstruction of rheumatoid hand deformities varies widely across the United
States, driven by both regional availability of subspecialty care in rheumatology and individual patient
factors. (First Release Jan 15 2015; J Rheumatol 2015;42:429–36; doi:10.3899/jrheum.140658)
Key Indexing Terms:
RHEUMATOID ARTHRITIS

HAND

WRIST

Rheumatoid arthritis (RA) is a chronic, debilitating,
immune-mediated disease involving progressive joint
destruction, commonly affecting the small joints of the hand
and wrist. Unfortunately, the incidence and prevalence of
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SURGERY

MEDICARE

ELDERLY

RA are rising among older individuals1,2. Although there is
no cure, surgical intervention, such as joint arthrodesis and
arthroplasty, can improve pain and deformity for patients
with RA, and many patients report improved satisfaction
and independence in daily life3,4,5.
Nonetheless, the role of surgery for RA remains controversial. Many clinicians view surgery as a failure of medical
management, and prospective cohort studies in several
countries suggest a declining rate of RA-related joint procedures6,7,8,9, likely attributable to advances in medical
therapy10. In the United States, rheumatologists and
surgeons debate the effectiveness, timing, and indications
for surgery, and studies have demonstrated large area
variation in the rate of hand surgery among patients with
RA11,12. Given this uncertainty, rates of surgery may
represent systematic differences in access to appropriate,
high-quality subspecialty care.
Currently, the factors that are correlated with undergoing
RA-related hand and wrist surgery are unknown, but could
reveal differences in access to care, physician practice
patterns, and treatment effectiveness. In this context, we
examined the rates of surgical procedures performed for
rheumatoid hand and wrist deformities among all Medicare
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(elderly) beneficiaries diagnosed with RA from 2006 to
2010 to (1) define the national variation in RA-related hand
and wrist surgery, and (2) identify the patient and regional
factors that influenced this variation. We hypothesized that
measurable variation existed in the rates of surgery among
elderly patients with rheumatoid hand and wrist deformities
because of both patient and regional factors.
MATERIALS AND METHODS

Study sample and data source. The study sample was drawn from 100%
Medicare beneficiaries who were diagnosed with RA and enrolled in
fee-for-service programs between 2006 and 2010. To increase the reliability
of the diagnosis of RA, the study cohort included beneficiaries with at least
2 diagnoses of RA [International Classification of Diseases, 9th ed (ICD-9)
codes for RA: 714.0, 714.1, 714.2, 714.3, 714.4] listed > 7 and < 365 days
apart between 2006 and 201013. Additionally, we included beneficiaries
aged ≥ 65 years who were continuously enrolled in Medicare Part A and B
during each calendar year. We excluded all beneficiaries who were enrolled
in Medicare Advantage Plans (Part C) because of the lack of outpatient
claims data in the Centers of Medicare and Medicaid Services (CMS)
databases. Using residence postal code, we further limited our analysis to
beneficiaries who resided within the 50 states and District of Columbia
during the study period. Each study subject entered the cohort in the year
of first diagnosis of RA, and remained in the cohort until the year of death,
disenrollment, or end of our study.
We specifically reviewed all outpatient services for the RA cohort
during the study period drawn from the outpatient files and the carrier files.
We obtained demographic data and confirmed enrollment status using the
Annual Beneficiary Summary Files. The outpatient files contained all
fee-for-service claims submitted by outpatient providers, and the carrier
files contained claims submitted by noninstitutional providers such as
physicians, physician assistants, and nurse practitioners. Both files use
ICD-9 codes to detail diagnosis, and Current Procedural Terminology
(CPT) codes to detail procedures.
Dependent variables. Our outcome variables included RA-related hand and
wrist surgical procedures identified by CPT codes (Table 1). Arthrodesis
procedures included carporadial, carpometacarpal (CMC), metacarpophalangeal (MCP), and interphalangeal (IP) joint arthrodesis. Arthroplasty
procedures included reconstruction with or without implants of the MCP,
IP, CMC, intercarpal, and wrist joints. We also included tendon reconTable 1. RA-related procedures of the hand and wrist.
Procedure Anatomic Location
Arthroplasty

Arthrodesis
Tenolysis
Tendon repair

Tendon transfer

Wrist
Intercarpal or CMC joints
MCP joint
IP joint
Wrist
CMC joint
MCP joint
IP joint
Extensor tendon, hand, finger, forearm
Proximal PIP joint
Digital joint
Extensor tendon, hand, finger
Extensor tendon, central slip
Ring, small fingers
All 4 fingers

structive procedures, specifically tenolysis, extensor tendon repair, and
tendon transfers.

Patient factors in independent variables. We examined the characteristics
of each study subject at their entry into the study cohort. We specifically
included age (categorized as 65–69 yrs, 70–74 yrs, 75–80 yrs, and ≥ 80
yrs), race (white, African American, and other), sex, and socioeconomic
status (SES). SES was estimated using postal code of beneficiary residence
and then grouped into 3 categories (high, medium, and low)14. As an
additional measure of SES, we examined whether each beneficiary
received state assistance in Medicare premiums using the “Medicare State
Buy-in” variable in the Beneficiary Summary File. We identified these
recipients if the beneficiary received the assistance for more than 6 months
in the year entering the cohort. Additionally, we controlled for the overall
health condition of study subjects in our analysis using Elixhauser comorbidity index15. Finally, we determined rural and urban residence for each
subject using the 1993 US Department of Agriculture Rural-Urban
Continuum Codes for Metro and Non-metro Counties16. Counties were
labeled by their Federal Information Processing Standards (FIPS) codes
and categorized into metropolitan counties (codes 1–3), non-metropolitan
counties with more than 2500 urban population (codes 4–7), and
completely rural counties (codes 8–9) in this database. We used the SAS
9.2 postal code help file, containing crosslink of postal code and FIPS code
for each county in the United States, to link the FIPS code in the
Rural-Urban Continuum Codes file to the residence postal code of the study
cohort, to assign rural status for each patient.

Regional factors. Hospital referral regions (HRR) were defined by the
Dartmouth Atlas of Health Care and represented regional healthcare
markets for tertiary medical care, including 306 distinct regions in the
United States according to patterns of hospital use17. We assigned each
subject in the study cohort to an HRR by postal code of permanent
residence regardless of where the procedure was performed for the patient.
To understand the effect of regional availability of specialist care, we
obtained density of rheumatologists, orthopedic surgeons, and plastic
surgeons within each HRR. This was detailed in the Dartmouth Atlas of
Health Care as the number of specialists per 1 million residents per region.
We then categorized provider density into evenly distributed tertiles.
To understand the effect of regional patterns of medical therapy, we
calculated the rate of use of biologic disease-modifying antirheumatic
drugs (DMARD) by each HRR. We identified use of biologic DMARD
from Medicare outpatient claims and Medicare Part D Prescription Drug
events by Healthcare Common Procedure codes and generic name of drugs
CPT Codes

25332, 25441
25447
26530, 26531
26535, 26536
25800, 25805, 25810, 25820, 25830
26841, 26843, 26844
26850, 26852, 26853
26860, 26861, 26862, 26823
26445, 26449
26460
26471, 26474
26410, 26412, 26418, 26420
26426, 26428
26497
26498

No. Patients
63
307
1322
390
420
58
428
737
86
75
45
175
54
72
50

Annual Rate*
0.5
2.6
11.3
3.3
3.6
0.5
3.7
6.3
0.7
0.7
0.4
1.5
0.5
0.6
0.4

* Annual rate was calculated as no. patients with RA who received the procedure per 10,000 patients per year. RA: rheumatoid arthritis; CPT: Current
Procedural Terminology; PIP: proximal interphalangeal; CMC: carpometacarpal; MCP: metacarpophalangeal; IP: interphalangeal.
430
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(Appendix 1). We calculated the annual rate of biologic DMARD use for
each HRR as average percent of patients with RA who received biologic
DMARD from 2006 to 2010.

Statistical analysis. We used descriptive statistics to detail the overall rates
of RA-related hand and wrist surgery, and the sociodemographic characteristics of the study population. We then constructed multivariate logistic
regression models to understand the effect of patient and regional factors on
RA-related hand and wrist surgery. To examine the influence of regional
availability of specialists on RA-related surgery, we also included in the
model the density of orthopedic surgeons, plastic surgeons, and rheumatologists in the region where each study subject resided, as predictors of
receiving RA surgery. Finally, we adjusted each model for number of years
in the study cohort and regional density of biologics therapy.

RESULTS
In our cohort of Medicare beneficiaries, we identified
356,061 individuals diagnosed with RA (Table 2). In this
cohort, 2895 patients underwent RA-related hand and wrist
reconstructive surgery during the period (annual rate =
24.8/10,000 patients). Among patients who underwent
surgery, 2693 had hand or wrist arthroplasty or arthrodesis
(annual rate = 23.1/10,000 patients) and 488 had tendon
reconstruction (annual rate = 4.2/10,000 patients). MCP
joint arthroplasty was the most commonly performed
surgery (annual rate = 11.3/10,000 patients), followed by
interphalangeal joint arthrodesis (annual rate = 6.3/10,000
patients). Among tendon reconstruction procedures,
extensor tendon repair was most commonly performed
(annual rate = 1.5/10,000 patients; Table 1).
Figure 1 demonstrates the crude rates of RA-related hand
and wrist surgery across the United States. Across HRR,
annual rates of surgery varied 9-fold, ranging from no
surgeries performed in 4 small regions in the east or south of
the United States (Lancaster, Pennsylvania; Longview,
Texas; Houma, Los Angeles; and Muskegon, Michigan) to
more than 80 per 10,000 patients (Ogden, Utah; Grand
Forks, North Dakota; Fort Collins, Colorado). Clusters of
high annual rates of RA-related hand and wrist surgery
appeared in the West Coast and Central areas of the United
States, and clusters of low surgical rates appeared in eastern
states, such as New York, Pennsylvania, South Carolina,
Georgia, and Florida.
Patient factors significantly influenced receipt of hand
and wrist surgery for RA, specifically age, sex, race, and
SES (Table 3). For example, patients with RA aged ≥ 80
years were less likely to undergo hand or wrist arthroplasty
and/or arthrodesis compared with patients aged 65–69 years
(OR 0.29, 95% CI 0.25–0.34). Women were more likely to
undergo arthroplasty and/or arthrodesis compared with men
(OR 2.05, 95% CI 1.85–2.28), and African American
patients were less likely to undergo joint procedures
compared with whites (OR 0.58, 95% CI 0.48–0.70).
Compared with patients who lived in metropolitan counties,
patients who lived in rural areas were more likely to undergo
arthroplasty and/or arthrodesis (OR 1.31, 95% CI
1.04–1.66). Finally, patients of higher SES were more likely

Table 2. Characteristics of the study cohort.
Characteristics

Age, yrs
65–69
70–74
75–79
≥ 80
Sex
Male
Female
Race
White
African American
Other
SES
Low
Medium
High
State assistance on Medicare premium
No
Yes
Rural status
Metropolitan county
Non-metropolitan county
Completely rural
Density of orthopedic surgeons†
Low, fewer than 58
Medium, 58 to 67
High, more than 67
Density of plastic surgeons†
Low, fewer than 15
Medium, 15 to 21
High, more than 21
Density of rheumatologists†
Low, fewer than 9
Medium, 9 to 13
High, more than 13
Regional rate of biologics use‡
Low, 1.0% to 4.3%
Medium, 4.3% to 5.6%
High, 5.6% to 13.6%

No. Patients

%

112,252
89,542
76,155
78,112

32
25
21
22

315,407
26,290
14,364

89
7
4

92,595
263,466

79,725
96,135
180,201

26
74

22
27
51

319,861
36,200

90
10

115,373
120,331
120,357

32
34
34

117,602
117,159
121,300

33
33
34

287,893
60,340
7828

117,763
118,437
119,861

115,850
120,507
119,704

81
17
2

33
33
34

33
34
34

Density of specialists is number of specialists in each hospital referral
region per 1 million residents in the region. ‡ Average rate of biologics
between 2006 and 2010 was calculated for each hospital referral region in
the United States as percent of patients with RA who received biologics
therapy during the study period. SES: socioeconomic status; RA:
rheumatoid arthritis.
†

to undergo arthroplasty and/or arthrodesis compared with
patients of lower SES (OR 1.20, 95% CI 1.08–1.34).
Tendon reconstruction was also influenced by patient
factors. Similar to joint reconstructive procedures, younger
(OR 2.63, 95% CI 1.89–3.57), female patients (OR 1.64,
95% CI 1.30–2.07) were more likely to undergo tendon
reconstruction compared with older, male patients.
Additionally, African American patients (OR 0.65, 95% CI
0.42–1.00) and patients of lower SES (OR 0.71, 95% CI
0.54–0.96) were less likely to undergo tendon reconstruction. Finally, patients who lived in rural areas were
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Figure 1. Annual rate of RA hand and wrist surgery (per 10,000 patients with RA) among US Medicare beneficiaries in 306 hospital referral regions,
2006–2010. RA: rheumatoid arthritis.

more likely to undergo reconstruction (OR 1.92, 95% CI
1.19–3.09) compared with patients who lived in urban areas
(Table 3).
We examined the effect of regional density of specialists
on RA-related hand and wrist surgery. In our cohort, patients
who resided in areas with a high density of orthopedic
surgeons were more likely to undergo arthroplasty and/or
arthrodesis (OR 1.16, 95% CI 1.05–1.29) compared with
patients who lived in areas with a lower density of orthopedic surgeons. The effect of plastic surgeon density was
less uniform, and patients who lived in areas with a
moderate density of plastic surgeons were more likely to
undergo arthroplasty and/or arthrodesis compared with
patients who lived in areas with a lower density of plastic
surgeons (OR 1.10, 95% CI 1.01–1.21). However, the same
effect was not seen among patients living in areas with the
highest density of plastic surgeons. Surgeon density did not
influence tendon reconstruction procedures. Alternatively,
regional density of rheumatologists was significantly
associated with likelihood of receiving hand and wrist
arthroplasty and arthrodesis among patients with RA.
Patients who lived in areas with more than 13 rheumatologists/1 million residents were significantly less likely to
undergo surgery (OR 0.76, 95% CI 0.69–0.85) compared to
patients who lived in areas with fewer than 10 rheumatologists/1 million residents (Table 3). We then examined the
crude and adjusted rates of arthroplasty and arthrodesis,
stratified by rheumatologist density (Figure 2). Even after
adjusting for other patient and regional factors, rates of
surgery remained lower in areas with a higher density of
rheumatologists. After controlling for all patient and
provider characteristics, regional density of biologics use
was not significantly correlated with rate of RA-related
hand and wrist surgery.
432

Finally, we examined the differences in patient characteristics among individuals who resided in areas of low,
medium, and high rheumatologist density (Table 4). In our
cohort, age, sex, race, SES, and rural status were significantly associated with the area of residence. For example, in
areas with a high density of rheumatologists, 25% of
patients with RA were ages ≥ 80 years and 29% were 65–69
compared with lower-density areas, in which 19% of
patients were ≥ 80 years and 34% were ages 65–69 (p <
0.001). Areas with a high density of rheumatologists also
had significantly more metropolitan patients (89% vs 74%,
p < 0.001). Finally, higher-density areas were also associated with a greater percentage of high SES patients (66% in
high density areas vs 40% in low density areas, p < 0.001).

DISCUSSION
RA remains common among older individuals, afflicting
over 350,000 Medicare beneficiaries from 2006 to 2010. In
our study, we identified a low rate of RA-related hand and
wrist reconstructive procedures among the elderly population in the United States, but found substantial variation in
RA-related hand and wrist procedures driven by patient and
regional factors. Patients who lived in areas with a greater
number of rheumatologists were less likely to undergo
RA-related hand and wrist joint fusion and replacement.
Additionally, younger, female, white patients with RA and
patients who resided in rural areas were more likely to
undergo both arthroplasty/arthrodesis of hand and wrist, and
hand tendon reconstruction. Finally, in our cohort, patients
of lower SES underwent fewer surgical procedures,
including both joint and tendon reconstruction. Although the
reasons for this are likely multifactorial, it is possible that
individuals of lower SES lack access to appropriate
specialist care, have additional comorbid conditions
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Table 3. Patient characteristics of the study cohort and adjusted OR of receiving RA-related hand or wrist surgery during the study period.
Patient Characteristics

Age, yrs
65–69
70–74
75–79
≥ 80
Sex
Male
Female
Race
White
African American
Other
SES
Low
Medium
High
State financial assistance on Medicare premium
No
Yes
Rural status
Metropolitan county
Non-metropolitan county
Completely rural
Density of orthopedic surgeons
Low, fewer than 58
Medium, 58 to 67
High, more than 67
Density of plastic surgeons
Low, fewer than 15
Medium, 15 to 21
High, more than 21
Density of rheumatologists
Low, fewer than 9
Medium, 9 to 13
High, more than 13
Regional rate of biologics use
Low, 1.0% to 4.3%
Medium, 4.3% to 5.6%
High, 5.6% to 13.6%

Arthroplasty/Arthrodesis
OR (95% CI)*
p

1
0.93 (0.85–1.02)
0.68 (0.61–0.76)
0.29 (0.25–0.34)
1
2.05 (1.85–2.28)

1
0.58 (0.48–0.70)
0.79 (0.63–0.98)
1
1.15 (1.03–1.29)
1.20 (1.08–1.34)

1
1.01 (0.88–1.15)

1
1.13 (1.02–1.26)
1.31 (1.04–1.66)

1
1.00 (0.91–1.11)
1.16 (1.05–1.29)

1
1.10 (1.01–1.21)
0.95 (0.85–1.05)

1
0.97 (0.88–1.07)
0.76 (0.69–0.85)

1
0.97 (0.89–1.07)
0.96 (0.88–1.06)

—
0.12
< 0.001
< 0.001
—
< 0.001

—
< 0.001
0.03
—
0.01
0.001
—
0.93

—
0.02
0.02

—
0.99
0.004
—
0.04
0.32

—
0.54
< 0.001
—
0.60
0.46

Tendon Reconstructive Procedures
OR (95% CI)*
p

1
1.13 (0.91–1.40)
0.82 (0.64–1.06)
0.38 (0.28–0.53)
1
1.64 (1.30–2.07)

1
0.65 (0.42–1.00)
0.80 (0.47–1.35)
1
1.35 (1.02–1.77)
1.41 (1.08–1.85)

1
0.79 (0.55–1.13)

1
0.96 (0.73–1.25)
1.92 (1.19–3.09)

1
0.87 (0.69–1.10)
0.91 (0.71–1.15)
1.06 (0.85–1.32)
1.05 (0.82–1.33)

1
1.10 (0.88–1.38)
0.97 (0.75–1.24)

1
1.11 (0.88–1.38)
1.01 (0.81–1.27)

0.26
0.13
< 0.001
< 0.001
0.05
0.40
0.03
0.01
0.19
0.76
0.007
0.26
0.43
0.61
0.71
0.41
0.80
0.38
0.90

* Adjusted OR of receiving hand and wrist arthroplasty/arthrodesis or tendon reconstruction during the study period, adjusting simultaneously by age, sex,
race, number of comorbid conditions, SES, state financial assistance, rural status, density of specialists, and regional rate of biologics use, as well as number
of years each individual stayed in the study cohort. SES: socioeconomic status; RA: rheumatoid arthritis.

precluding aggressive medical or surgical intervention, or
have fewer available financial resources. Since Alderman, et
al12 in 2002 described regional differences in rheumatoid
hand and wrist reconstruction using national claims data,
pronounced variation in RA treatment continues to persist.
Our findings suggest the influence of providers on these
differences. First, surgical rates may represent differential
access to subspecialty care, particularly to rheumatologists
with expertise in inflammatory arthropathies. In the United
States, a relative shortage of rheumatologists exists, and
many patients with RA are managed by providers who do
not have subspecialty training, who may opt for less-aggressive immunosuppressive regimens, particularly among older

individuals18. Individuals without access to newer DMARD
may progress more quickly toward advanced deformities,
resulting in higher rates of surgical therapy among those
patients treated in areas with fewer rheumatologists.
Additionally, our findings may represent differences in
referral patterns for surgical intervention. Rheumatologists
are often skeptical of the effectiveness of surgical interventions for RA, which influences referral rates for extremity
surgery. Lower rates of surgery in some areas may reflect
not only differences in aggressiveness of medical therapy,
but also differences in treatment preferences19,20.
The majority of patients are referred to rheumatologists
by primary care physicians following the diagnosis of RA,
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Figure 2. Crude and adjusted rate of RA-related hand and wrist surgery among Medicare
beneficiaries who lived in areas of different quartiles of rheumatologist density. * p < 0.05,
from multivariate logistic regression model, adjusting simultaneously by all patient characteristics and number of years in study cohort. RA: rheumatoid arthritis.
Table 4. Distribution of baseline patient characteristics by density of
rheumatologists of the hospital referral region. Values are % unless
otherwise specified.
Patient Characteristics

Age, yrs
65–69
70–74
75–79
≥ 80
Sex
Male
Female
Race
White
African American
Other
SES
Low
Medium
High
Missing
Rural status
Metropolitan county
Non-metropolitan county
Completely rural

SES: socioeconomic status.

Density of Rheumatologists
Low
Medium
High

p

34
26
21
19

32
25
21
22

29
24
22
25

< 0.001

90
6
3

87
7
5

88
8
4

< 0.001

27
73

25
31
40
4

74
22
3

26
74

20
29
48
4

80
18
2

25
75

< 0.001

11
21
66
2

< 0.001

89
9
1

< 0.001

and surgeons are rarely the initial treatment provider. In the
United States, about 70% of hand surgeons are trained in
orthopedic surgery, 20% in plastic surgery, and 10% in
general surgery21. In our study, we identified a significant
difference in rates of surgery by density of orthopedic
434

surgeons. Surgeons often perceive that medical therapy is
extended into advanced stages of RA, making it impossible to reconstruct functionally and aesthetically
acceptable hands12,19. To date, 1 of the largest prospective cohort studies of patients with rheumatoid hand
deformities revealed that patients with RA treated with
silicone metacarpophalangeal arthroplasty continue to
experience longterm improvement in hand function and
appearance compared with patients managed medically.
Therefore, despite this controversy, surgery remains an
important option to relieve pain and improve function,
hand appearance, and quality of life among patients with
RA22.
Geographic variation in care is common across the
United States23,24,25. Although such variation is thought to
represent differences in quality of care, the reasons for this
are multifactorial23,26. Our analysis in Figure 1 represents
the unadjusted rates across HRR in the United States. Our
multivariate analysis does highlight several patient factors,
such as age and sex, and regional factors, such as rheumatologist density, that explain the variation in rates. However,
collectively, these factors explain only 0.3% of the variation,
and unmeasured factors certainly exist. For example, our
study lacks detail in clinical factors that may influence
surgery, such as disease severity, and does not identify
patient preferences for treatment19. It is also plausible that
there is underlying geographic variation in the incidence of
RA. An analysis of the Nurses’ Health Study revealed an
increased incidence of RA among women in New England
and the Midwest27. Although the etiology of RA remains
unknown, there is likely regional variation in risk factors,
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such as genetic pools or environmental factors that have yet
to be identified28.
Our study has several notable limitations. First, administrative data were subject to systematic coding errors and
were not collected with the explicit purpose of examining
practice patterns. However, we required at least 2 claims,
including an RA diagnosis, to ensure the validity of our
selected cohort, and a study comparing diagnoses between
office records and Medicare claimed to have found a 90%
correlation between diagnoses29. Owing to the stringency of
our criteria, it was possible that patients with RA with
limited access to care could be excluded from the cohort.
Additionally, we excluded Medicare Part C enrollees
(16–24% of all Medicare beneficiaries) because their outpatient services may not be found in administrative claims
data. Our study sample included only adults aged ≥ 65
years, and our findings may not have been generalizable to
younger individuals with RA30. Finally, we were not able to
examine the effect of disease severity or chronicity on
surgical rates, given the lack of granular detail of claims
data at this level. Without clinical data, such as laboratory
findings, symptomatology, and radiographic progression,
we could not account for the influence of disease severity on
rates of surgery. Nonetheless, Medicare data have been
widely used to examine treatment patterns and provide
robust data because of large, population-based samples.
Compared with clinical trials or observational registries that
are biased toward tertiary care centers, CMS claims data
reflect real-world clinical practice29,31,32,33.
Despite these limitations, our findings reveal significant
variation in RA treatment pattern by availability of rheumatologists, and highlight important areas for future investigation. First, access to appropriate healthcare resources has
been central to healthcare reform initiatives in the United
States. Several interventions, such as the expansion of
prescription drug coverage through Medicare Part D and the
expansion of Medicaid (low-income) coverage from the
Patient Protection and Affordable Care Act, may minimize
disparities in access to care for chronic diseases. For
example, the initiation of Medicare Part D coverage of
biologic DMARD therapy for RA has improved use among
vulnerable groups34,35. Additionally, healthcare reform
initiatives have included specific provisions for comparative
effectiveness research. Given the controversy that remains
regarding the effectiveness of medical and surgical therapy
for rheumatoid hand deformities, future studies that directly
compare the effectiveness of surgical therapy in the setting
of advanced medical therapies, such as biologic DMARD,
may allow for better integration of treatment options
between rheumatologists and surgeons.
Surgical reconstruction of rheumatoid hand deformities
varies across the United States because of the availability of
rheumatologists and patient characteristics. Future efforts
that directly examine access to healthcare services, surgery

referral pattern, and effectiveness of medical and surgical
treatment options, as well as health policy interventions
aimed at improving access to care, can minimize unwarranted variation in the management of rheumatoid hand and
wrist deformities.
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APPENDIX 1. Healthcare Common Procedure Codes and generic name
of biologic DMARD.

Generic Name

Abatacept/maltose
Adalimumab
Anakinra
Certolizumab pegol
Etanercept
Golimumab
Infliximab
Rituximab
Tocilizumab
Tofacitinib

Healthcare Common Procedure Codes

DMARD: disease-modifying antirheumatic drug.

J0219
J0135
—
J0718
J1438
—
J1475
J9310
—
—
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